A multicenter study of recombinant human erythropoietin (epoetin alpha) in the management of anemia in cancer patients receiving chemotherapy.

M, Pawlicki; J, Jassem; P, Bösze; C, Lotan; GP, Kurteva; M, Siddiqui; PA, Kosmidis; GA, Rigatos; E, Kansu; P, Durkovic; Z, Aziz; Idrissi H, Al; A, Roth; G, Cozma

doi:10.1097/00001813-199711000-00006

Public

A multicenter study of recombinant human erythropoietin (epoetin alpha) in the management of anemia in cancer patients receiving chemotherapy.

Shared by NobleBlocks on Nov 1, 1997 • 12:00 AM UTC

Authors:

Pawlicki M

Jassem J

Bösze P

Abstract

Current evidence suggests that epoetin alpha administration is well tolerated and effective in the management of anemia of cancer and cancer chemotherapy. An open-label, multinational, non-comparative study was conducted in 215 cancer patients with anemia secondary to chemotherapy with platinum- or ...

Discussions